-
Courses
Courses
Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
-
University Life
University Life
Each year more than 4,000 choose University of Galway as their University of choice. Find out what life at University of Galway is all about here.
-
About University of Galway
About University of Galway
Since 1845, University of Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
-
Colleges & Schools
Colleges & Schools
University of Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a range of key areas of expertise.
-
Research & Innovation
Research & Innovation
University of Galway’s vibrant research community take on some of the most pressing challenges of our times.
-
Business & Industry
Guiding Breakthrough Research at University of Galway
We explore and facilitate commercial opportunities for the research community at University of Galway, as well as facilitating industry partnership.
-
Alumni & Friends
Alumni & Friends
There are 128,000 University of Galway alumni worldwide. Stay connected to your alumni community! Join our social networks and update your details online.
-
Community Engagement
Community Engagement
At University of Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
News
Research breakthroughs advance Type 1 diabetes cell therapy
Research breakthroughs from Rinn Medical Devices at University of Galway are addressing a major obstacle for cell therapies as a potential treatment for Type 1 diabetes. Two recent research studies have found a way to keep fragile insulin-producing cells alive and functional between their manufacture and delivery to patients. Historically, these cells often perish during transportation due to exposure to harmful oxidants that lead to cell damage. In the first study, published in the Journal of Materials Chemistry B, Dr Amir Alsharabasy and Professor Abhay Pandit set out how their research has developed a new vitamin C hydrogel to protect insulin-producing cells. The team attached vitamin C to hyaluronan, a natural substance found in the body's tissues. In laboratory tests, lab-grown insulin-producing cells that were exposed to harmful oxidants had healthier energy production when protected by the gel. The cells also released about 41 per cent more insulin in response to glucose than cells in a standard gel, and showed fewer signs of stress during storage. Dr Amir Alsharabasy, Rinn Medical Devices, University of Galway, said: "Cells that make insulin are very easily damaged by oxidative stress when they are handled and stored. By building vitamin C into the gel itself, the protection stays right next to the cells instead of washing away." Professor Abhay Pandit, Director of Rinn Medical Devices at University of Galway, said: "These are early but encouraging, laboratory-based results using cell lines. The next step is to test the gel with real insulin-producing cells and stem-cell-derived cells, which are much closer to what a patient would receive."In another related study, scientists from University of Galway - Dr Daniel Domingo-Lopez, Dr Ruth Tarpey, Professor Garry Duffy and Dr Ruth Levey, published results of their research on the development of a new dual-chamber device that supplies oxygen to cells through a gas-permeable membrane in the Advanced Functional Materials journal. Dr Ruth Levey, Institute for Health Discovery and Innovation, University of Galway, said: “Many of today's cell therapies have to be frozen and kept ultra-cold the whole way from the lab to the patient which needs specialist equipment, is expensive and can damage the cells. In practice, it means that access to these therapies is very limited. Our device keeps the cells fresh and supplied with oxygen, so they can travel using standard courier networks with the aim of making it easier for these therapies to reach more patients, wherever they live.” Insulin-producing cells are particularly difficult to transport because they are highly sensitive to low oxygen and do not survive freezing well. As part of the study, insulin-producing cells shipped from Ireland to Italy at ambient temperature showed around 80 per cent viability after 48 hours and formed functional insulin-secreting clusters, unlike cells that had been frozen and thawed using standard transport methods. A computer model of how oxygen moves through the device, suggests one device could transport 2,000 to 2,500 human islets, the clusters of insulin-producing cells found in the pancreas, for 48 hours. Professor Garry Duffy, Director of the ARC Hub for Healthtech and Principal Investigator at Rinn Medical Devices at University of Galway, said:: "Human islet validation is the essential next step, but we hope that the platform can be adapted to many cell types. For patients, higher-quality cells could mean more reliable treatments and, eventually, less reliance on insulin injections. Professor Abhay Pandit added: "At Rinn Medical Devices, we bring materials scientists, engineers, biologists and industry partners together because no single field could solve this on its own. Both studies show what becomes possible when disciplines work side by side. One tackled a chemistry problem, protecting cells with a vitamin C-bonded gel. The other tackled an engineering problem, delivering oxygen during transport. Each group solved a different piece of the puzzle, and that is how promising ideas reach patients faster." The work involved researchers from Rinn Medical Devices, the University of Galway's regenerative medicine institute REMEDI, the University of Limerick, Trinity College Dublin, RCSI and Explora Biotech in Rome, and was backed by Research Ireland and European funding. Ends
Ireland’s best young science filmmakers announced
University of Galway leads nationally with 13 Research Ireland Public Service Fellowships
Universal Design Conference to welcome global leaders in inclusion
Friday, 16 December 2022
All eligible University of Galway full time and part time hourly payscales have been updated in line with the provisions of Building Momentum - A New Public Service Agreement 2021-22. Specifically the following increases have been implemented: - With effect from 02nd February 2022, payscales received a 3% increase - With effect from 01st October 2022- payscales received a further 1% increase or €500, whichever is greater We are still awaiting sanction for the implementation of FEMPI restoration wef 1st July 2022 (save for a limited number of pay scales). Therefore there are no changes to those grades\pensions for now. See paragraph 1.3 in the above link for more details. Further advice will be issued for these grades in due course.
Monday, 24 April 2023
We have been asked to bring to your attention the fact that Secondment Expression of Interest Notices has been issued for the Public Service Transformation Division of the Department of Public Expenditure, NDP Delivery and Reform. Expressions of interest are invited from across all sectors of the Public Service, including higher education, and across a number of grades. Notices are available directly at the following link, and DPENDR and DFHERIS would very much appreciate your support in circulating to your staff. The closing date for applications is 2nd May, and we understand the notices issued on Friday 14th April.










